Theralase Technologies Inc. (TSXV:TLT)

Theralase Technologies Ratios and Metrics

Market cap in millions CAD. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 22, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	63	44	66	40	69	77
Market Cap Growth	44.53%	-33.43%	64.23%	-42.29%	-9.56%	97.37%
Enterprise Value	64	44	66	40	67	72
Last Close Price	0.23	0.17	0.27	0.17	0.32	0.38
PS Ratio	77.70	53.54	63.54	37.35	60.85	98.13
PB Ratio	35.68	24.59	31.76	20.98	22.40	15.11
P/TBV Ratio	35.68	24.59	31.76	20.98	22.40	15.11
EV/Sales Ratio	78.04	53.83	63.53	37.52	59.13	91.82
Debt / Equity Ratio	0.26	0.26	0.14	0.20	0.15	0.01
Net Debt / Equity Ratio	0.16	0.16	0.01	0.18	-0.33	-0.72
Net Debt / EBITDA Ratio	-0.07	-0.07	-0.01	-0.08	0.21	0.85
Net Debt / FCF Ratio	-0.08	-0.08	-0.01	-0.08	0.20	0.89
Asset Turnover	0.24	0.24	0.32	0.29	0.23	0.10
Inventory Turnover	0.59	0.59	0.80	0.89	0.97	0.92
Quick Ratio	0.85	0.85	0.99	0.60	2.86	4.56
Current Ratio	1.25	1.25	1.61	1.39	3.67	5.71
Return on Equity (ROE)	-214.33%	-214.33%	-214.26%	-182.91%	-128.27%	-61.98%
Return on Assets (ROA)	-77.42%	-77.42%	-82.17%	-77.21%	-64.71%	-35.56%
Return on Capital Employed (ROCE)	-223.10%	-223.10%	-189.70%	-208.90%	-150.40%	-89.60%
Earnings Yield	-6.50%	-9.43%	-6.48%	-11.43%	-7.56%	-5.76%
FCF Yield	-5.26%	-7.63%	-5.10%	-10.28%	-7.47%	-5.39%
Buyback Yield / Dilution	-7.28%	-7.28%	-9.14%	-5.79%	-1.79%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.